Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Buy
440,738
+1,800
+0.4% +$2.74K 0.03% 320
2026
Q1
$794K Buy
438,938
+214,838
+96% +$371K 0.04% 291
2025
Q4
$303K Buy
224,100
+13,000
+6% +$18.5K 0.01% 435
2025
Q3
$344K Buy
211,100
+11,000
+5% +$12.2K 0.02% 381
2025
Q2
$194K Buy
+200,100
New +$166K 0.02% 455

Other funds holding OCGN

Procyon Advisors's OCGN Position: Q2 2026 in Review

Procyon Advisors increased its Ocugen (OCGN) stake by 0.41% in Q2 2026, buying an estimated $2.74K and bringing the position to 440,738 shares worth $674K. The position accounts for 0.03% of the portfolio, ranked #320.

Procyon Advisors first reported a position in OCGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $794K in Q1 2026. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Procyon Advisors held 440,738 shares of Ocugen worth $674K as of Q2 2026.
  • Procyon Advisors bought 1,800 Ocugen shares in Q2 2026, an estimated $2.74K.
  • Ocugen made up 0.03% of Procyon Advisors's portfolio in Q2 2026, its #320 holding.
  • Procyon Advisors first reported a position in Ocugen in Q2 2025 and has held it in 5 quarters since.
  • Procyon Advisors's Ocugen position peaked at $794K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.